Browse studies

Find your next paid study

27,333 recruiting studies available now

A Gender-Affirming Stigma Intervention to Improve Substance Misuse and HIV Risk Among Transgender Women

This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program i…

Substance AbuseSubstance AddictionSubstance Use Disorder (SUD)+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Illinois Institute of TechnologyNCT06880705

Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning

This study measures the utility of a novel artificial intelligence (AI) algorithm for performing auto-segmentation of computed tomography (CT) scans for radiat…

Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT06200116

Observational

A Pilot Randomized Controlled Trial of LDART, a Social Support Intervention for Alcohol Use Disorder

This study is a pilot randomized controlled trial to evaluate feasibility, acceptability, and preliminary efficacy of a digital intervention called Let's Do Ad…

Alcohol Use DisorderHazardous Alcohol Use

Estimated

~$10 – $750

Actual pay is set by the research site.

Yale UniversityNCT07221383

Phase 4

Pilot Trial of Belimumab in Early Lupus

This two year study will evaluate the effects of giving belimumab (Benlysta) to patients with Early Lupus. Early lupus is a diagnosis of lupus within 2 years. …

Lupus Erythematosus, SystemicLupus Erythematosus

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Northwell HealthNCT03543839

Phase 3

Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine

The main goal of the study is to assess the long-term safety of eptinezumab on children and adolescents ages 6 to 17 with chronic or episodic migraine.

Migraine

Estimated

~$50 – $2,250

Actual pay is set by the research site.

H. Lundbeck A/SNCT05164172

A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium

A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic erad…

Barrett's EsophagusEsophageal Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT02634645

ZEPOSIA® (Ozanimod) Ulcerative Colitis Pregnancy Registry: a Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women With Ulcerative Colitis and Their Offspring

The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.

Ulcerative Colitis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Bristol-Myers SquibbNCT05953402

Cellular and Physical Function Outcomes Leading to Failed Muscle Recovery After Critical Illness/Muscle and Physical Functional Recovery After Acute Critical Illness

The overarching goal of the proposed study is to determine the trajectories of physical recovery and cellular markers involved with the underlying failure to r…

ICU Acquired WeaknessPost Intensive Care Unit SyndromeMuscle Weakness+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Esther Dupont-VersteegdenNCT05537298

Phase 1

A Phase Ib/II, Open-label, Multi-centre, Platform Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Multiple Anti-Cancer Agents in Metastatic Prostate Cancer

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer age…

Metastatic Prostate Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT07590934

Phase 2

A Phase 2a, Multicenter, Randomized, Open-Label Study to Assess the Efficacy, Safety, and Tolerability of RBS2418 in Combination With Tremelimumab Plus Durvalumab for Participants With Advanced Unresectable Hepatocellular Carcinoma

RBS2418 is a targeted immune modulator that inhibits ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). It is designed to promote anti-tumor immunity …

Advanced Unresectable Hepatocellular Carcinoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Riboscience, LLC.NCT07175441

Phase 1

A Phase 1/2 Dose-exploration and Dose-expansion Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung Disease and/or Liver Disease

This is a Phase 1/2, multicenter, open-label study conducted in 3 parts (Part A, Part B, and Part C) to evaluate the safety, tolerability, PK/PD, and efficacy …

Alpha 1-Antitrypsin Deficiency

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Beam Therapeutics Inc.NCT06389877

Observational

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

This is a hybrid decentralized, single-arm, interventional study designed to evaluate the impact of precision medicine navigation and reflexive expert review o…

Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT06896162